Effects of Strength Training on the Gait and Pelvic Floor in Menopausal Women
1 other identifier
interventional
34
1 country
1
Brief Summary
The overall objective will be to observe whether a strength and balance training intervention produces significant changes in the analysis of double stance phase movement during gait, the analysis of coxofemoral, tibial and calcaneal joint movement during gait, pelvic floor contractile activity in standing and monopodal stability, stress urinary incontinence, fracture risk, sexual function and prolapse in sedentary menopausal women in the short and medium term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedSeptember 21, 2026
September 1, 2026
4 months
July 28, 2022
September 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pelvic Floor Muscle Activity During Gait
Mean root mean square (RMS) amplitude of the EMG signal of pelvic floor muscles recorded during 90 seconds of steady-state walking at self-selected speed using intracavitary electromyography (Mdurance®). Signals will be band-pass filtered (10-480 Hz), rectified, and processed using RMS.
Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)
Secondary Outcomes (2)
Gait Kinematics
Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)
Plantar Pressure Distribution
Baseline, Week 12 (post-intervention), Week 16 (1-month post-intervention), and Week 24 (3-months post-intervention)
Study Arms (2)
Sequence A (Strength Training first)
EXPERIMENTALParticipants will receive the strength training intervention (two 45-60 minute live online supervised sessions per week for 12 weeks) followed by a control/washout period.
Sequence B (Control first)
EXPERIMENTALParticipants will first complete a control period (no training sessions) for 12 weeks, followed by the strength training intervention.
Interventions
Two 45-60 minute sessions per week for 12 weeks of live online training supervised by a qualified exercise specialist/physiotherapist.
Eligibility Criteria
You may qualify if:
- Women aged 45 to 76 years.
- Menopausal (minimum 12 months of amenorrhea).
- Sedentary lifestyle (less than 30 minutes per day of regular exercise and less than 3 days per week according to WHO definition).
- Availability to participate in the study and attend all scheduled sessions.
- Able to read, write, and command spoken and written Spanish language.
- Diagnosis of urinary incontinence, pelvic organ prolapse, and/or sexual dysfunction.
You may not qualify if:
- Systemic disease.
- Cardiovascular disease.
- Vestibular and/or visual pathology (including vertigo, tinnitus, hypoacusis, or aural tinnitus).
- History of psychiatric illness.
- Cognitive deficits for any reason.
- Neurological injury.
- Use of walking aids, orthoses, or prostheses.
- Ingestion of vestibular sedatives or central nervous system depressants.
- Musculoskeletal diseases with lower limb deformity.
- Lower limb surgery within the last 10 years.
- Urogenital surgery.
- Latex allergy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Europea de Madrid
Madrid, Villaviciosa de ODON, 28670, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- At the end of the PI's assessment, they will be contacted by researcher 1 who will randomly assign participants to either the intervention or control group.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
July 28, 2022
First Posted
September 17, 2026
Study Start
April 1, 2023
Primary Completion
July 31, 2023
Study Completion
January 1, 2024
Last Updated
September 21, 2026
Record last verified: 2026-09